% Medical treatment 478.45 442.26 36.19 8.18 Medical service 24.70 16.18 8.53 52.70 Drugs and medical supplies 0.86 0.98 (0.12) (12.27) Other supplies 1.14 1.35 (0.22) (15.92) X-ray 11.30 10.09 1.21 11.97
Increase (Decrease) Amount % Medical treatment 104.71 111.67 (6.96) (6.24) Medical service 7.01 4.65 2.36 50.77 Drugs and medical supplies 0.18 0.21 (0.02) (11.02) Other supplies 0.22 0.17 0.05 30.82 X-ray
Australia. The project cost is approximately AUD 359 million. It is scheduled to enter construction in the first half of 2019 and is anticipated to commence operations in 2020. 1.3 Signing of financial
Table 7: Capital Expenditure 1Q2017 Bt 268 million 2Q2017 Bt 234 million 3Q2017 Bt 305 million 4Q2017 Bt 418 million An additional investment in Phase 3 of the new plant during 2017, will commence
following conditions: (1) the licensee shall commence operation of derivatives business in the category specified in the license only after the SEC Office having completed its inspection, is of the view that
business shall comply with the following conditions: (1) The licensee shall commence the undertaking of gold derivatives brokerage business only when the SEC Office verifies that the licensee has satisfied
derivatives brokerage business shall comply with the following conditions: (1) The licensee shall commence the undertaking of gold derivatives brokerage business only when the SEC Office verifies that the